 |
Neil Belmore
Direct: (416) 863-3350
Fax: (416) 863-9171
Email: neil.belmore@belmorelaw.com
Download Vcard
Neil is consistently rated by peer and client reviews as a leading advocate amongst intellectual property litigators:
- Chambers, Intellectual Property Litigation, 2012
- The International Who’s Who of Life Sciences Lawyers, 2012
- Lexpert® Law Directory since 1999
- Global Counsel 3000
- Martindale-Hubell Maximum Rating, 2007, 2008
- The Best Lawyers in Canada
- LawDay’s 35 Leading Lawyers in Canada - Intellectual Property Litigation
- Lexpert/American Lawyer Guide to the Leading 500 Lawyers in Canada, 2009 – one of eight leading IP litigators in Toronto
- An International Who’s Who of Patent Lawyers since 2000 Law Business Research Ltd., London
- Mondaq’s Guide to the Worlds Leading Professional Advisors in Copyrights, Patents and Trademarks, 2001
- Guide to the Worlds Leading Patent Law Practioners, 2009
Chambers Global, 2006 noted Mr. Belmore for having “prowess in pharmaceutical litigation”. He is singled out by an international client in the 'Guide to the Worlds Leading Patent Law Practitioners, 2009 Ed.', who describes the Toronto based partner as “my number one choice in Canada” and says “I go to Belmore first”. The client adds he has a “terrier instinct”, a “sharp, smart and efficient mind”, and is an “interesting man”. Neil is a frequent speaker and author on intellectual property law and practice.
He is a graduate of Osgoode Hall Law School in Toronto.
Publications
Expert witnesses: Drug Patents and Legal Forum
Expert Witnesses: From Proper Retention to Cross-Examination
The Access to Information Act; How it is being Applied to Health Canada's Pharmaceutical Files
Personal Privacy Initiatives in Canada and the U.S.
Interesting Recent and Pending Patent Cases
Changes in Federal Court Rules Motions and Interlocutory Applications
Patenting Software Related Business Methods
Trade Secret Law In Canada and The United States
Cross-examining the Expert Witness
Patented Medicines (Notice of Compliance) Regulations
Canadian Patent Infringement Remedies
Pharma Patent Litigation Strategies of the Applican/Plaintiff
Parallel Imports and Grey Market Issues
Interesting Times for the Protection of Software
Protecting Confidential Information
The Effect of International Agreements on The Patent Act
Interlocutory Injunctions and Summary Judgement in Trade-mark Cases
Back |